Media

Consilient Health is pleased to announce it has taken over the UK marketing of Detrunorm® (Propiverine)

As of January 2022, Consilient Health is pleased to announce it has taken over the UK marketing of Detrunorm® (Propiverine) in conjunction with our partner Apogepha.

Available in the 15mg x 56 tablets, 30mg x 28 MR Capsules, and 45mg x 28 MR Capsules,

All 3 SKU’s are available through Alliance wholesale.

For product details please visit our products page 

View more news and events

Share this page


Code No: UK-GEN-48
Date of Preparation: February 2022